Evaluation of the impact of baseline levels of MRI-detected inflammation on treatment response in early, seropositive, MTX-NAÏVE RA: data from the AVERT trial

H. Ahmad, J. Baker, Mikkel Østergaard, P. Emery, P. Durez, J. Ye, S. Banerjee, P. Conaghan

OriginalsprogEngelsk
TidsskriftAnnals of the Rheumatic Diseases
Vol/bind76
Udgave nummerSuppl 2
Sider (fra-til)174
Antal sider1
ISSN0003-4967
StatusUdgivet - 2017

Citationsformater